# Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation

> **NCT02581826** · PHASE2 · UNKNOWN · sponsor: **Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation** · enrollment: 40 (estimated)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** Silodosin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02581826
- **Lead sponsor:** Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02581826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02581826, "Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02581826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*